Delivery Order SPE2DR25D6028-SPE2DR26FARCW
Award Date 10/30/25
Potential Completion Date 10/31/25
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Sulfadiazine Cream with a ceiling value of $1,675.20. This firm fixed-price delivery order, which is not set-aside and competitively awarded, is scheduled for completion by October 9, 2025, with performance to take place at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for Silver Sulfadiazine 1% Cream in 85-gram units, with a ceiling value of $1,347.42. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract employs firm fixed pricing and was...
- The Defense Logistics Agency Medical Supply Chain awarded a $1,098.00 delivery order to AmerisourceBergen Drug Corp for Silver Sulfadiazine 1% Cream in 20-gram units. This firm fixed-price, competitively awarded contract was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility and carries no set-aside designation. As a child order under a larger contract vehicle, this delivery...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,664.83 to AmerisourceBergen Drug Corp on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The work will be performed at the contractor's corporate office in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $14,257.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, with completion expected by October 21, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order is to be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,337.50 to AmerisourceBergen Drug Corp on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed-price, non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be performed...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $4,216.30 to AmerisourceBergen Drug Corp on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award represents a pharmaceutical delivery to be...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $14,800.80 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract specifies...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,790.80 to AmerisourceBergen Drug Corp on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside...